Benet Nomdedeu

3.4k total citations
88 papers, 1.8k citations indexed

About

Benet Nomdedeu is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Benet Nomdedeu has authored 88 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 30 papers in Genetics and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Benet Nomdedeu's work include Acute Myeloid Leukemia Research (31 papers), Lymphoma Diagnosis and Treatment (15 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Benet Nomdedeu is often cited by papers focused on Acute Myeloid Leukemia Research (31 papers), Lymphoma Diagnosis and Treatment (15 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Benet Nomdedeu collaborates with scholars based in Spain, United States and Chile. Benet Nomdedeu's co-authors include Emili Montserrat, C Rozmán, Elisa Luño, Francesc Graus, Guillermo Sanz, Pedro Marı́n, E.M. Bessell, Arturo Pereira, Blanca Xicoy and Jordi Esteve and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Benet Nomdedeu

86 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benet Nomdedeu Spain 22 881 829 592 361 349 88 1.8k
Norifumi Tsukamoto Japan 25 826 0.9× 561 0.7× 706 1.2× 381 1.1× 433 1.2× 139 2.1k
Shin Fujisawa Japan 27 1.1k 1.2× 561 0.7× 410 0.7× 380 1.1× 572 1.6× 182 2.2k
Anne Lennard United Kingdom 20 414 0.5× 562 0.7× 831 1.4× 218 0.6× 561 1.6× 51 1.6k
Piero Galieni Italy 26 739 0.8× 564 0.7× 700 1.2× 487 1.3× 706 2.0× 89 1.7k
Bernard Lenormand France 20 355 0.4× 638 0.8× 949 1.6× 211 0.6× 512 1.5× 52 1.6k
Françoise Rigal‐Huguet France 25 1.3k 1.4× 837 1.0× 1.0k 1.7× 692 1.9× 869 2.5× 66 2.7k
Francesco Onida Italy 31 1.7k 1.9× 1.3k 1.5× 571 1.0× 506 1.4× 643 1.8× 118 3.0k
R. Kuse Germany 26 1.4k 1.6× 703 0.8× 763 1.3× 518 1.4× 734 2.1× 78 2.4k
Rajko Kušec Croatia 24 1.0k 1.2× 887 1.1× 341 0.6× 979 2.7× 280 0.8× 104 2.0k
Anna Porwit‐MacDonald Sweden 30 1.1k 1.3× 631 0.8× 938 1.6× 610 1.7× 604 1.7× 50 2.7k

Countries citing papers authored by Benet Nomdedeu

Since Specialization
Citations

This map shows the geographic impact of Benet Nomdedeu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benet Nomdedeu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benet Nomdedeu more than expected).

Fields of papers citing papers by Benet Nomdedeu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benet Nomdedeu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benet Nomdedeu. The network helps show where Benet Nomdedeu may publish in the future.

Co-authorship network of co-authors of Benet Nomdedeu

This figure shows the co-authorship network connecting the top 25 collaborators of Benet Nomdedeu. A scholar is included among the top collaborators of Benet Nomdedeu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benet Nomdedeu. Benet Nomdedeu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palomo, Laura, Meritxell Nomdedéu, Marina Díaz‐Beyá, et al.. (2018). Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML. Scientific Reports. 8(1). 13883–13883. 7 indexed citations
2.
3.
Martı́nez, Daniel, Amaia Sagasta, Ana Carrió, et al.. (2015). Paraspinal extramedullary hematopoiesis in hereditary spherocytosis with a concurrent follicular lymphoma: case report and review of the literature. Diagnostic Pathology. 10(1). 158–158. 2 indexed citations
4.
Bernal, Teresa, Pablo Martínez‐Camblor, Joaquín Sánchez‐García, et al.. (2015). Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry. Leukemia. 29(9). 1875–1881. 67 indexed citations
5.
Nomdedéu, Meritxell, Margherita Maffioli, Xavier Calvo, et al.. (2011). Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutation. Leukemia Research. 35(9). 1276–1278. 2 indexed citations
6.
González‐Porras, José Ramón, Esperanza Such, Benet Nomdedeu, et al.. (2011). The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome. Leukemia Research. 36(3). 287–292. 17 indexed citations
7.
Valcárcel, David, Vera Ademà, Mar Mallo, et al.. (2011). Prognostic Impact of Monosomal Karyotype in Patients with Myelodysplastic Syndrome and Abnormal Karyotype. A Report From the Spanish Group of MDS (GESMD). Blood. 118(21). 1724–1724. 2 indexed citations
8.
Costa, Dolors, Ana Carrió, Marı́a Rozman, et al.. (2010). Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?. Leukemia Research. 34(11). 1437–1441. 17 indexed citations
9.
Pons, Aina, Benet Nomdedeu, Alfons Navarro, et al.. (2009). Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leukemia & lymphoma. 1–6. 6 indexed citations
10.
Madrigal, Irene, Ana Carrió, Marı́a Rozman, et al.. (2006). Fluorescence in situ hybridization studies using BAC clones of the EVI1 locus in hematological malignancies with 3q rearrangements. Cancer Genetics and Cytogenetics. 170(2). 115–120. 8 indexed citations
11.
Bessell, E.M., Armando López‐Guillermo, S. Villà, et al.. (2002). Importance of Radiotherapy in the Outcome of Patients With Primary CNS Lymphoma: An Analysis of the CHOD/BVAM Regimen Followed by Two Different Radiotherapy Treatments. Journal of Clinical Oncology. 20(1). 231–236. 72 indexed citations
12.
Bladé, Joan, Marı́a Perales, Laura Rosiñol, et al.. (2001). Thalidomide in multiple myeloma: lack of response of soft‐tissue plasmacytomas. British Journal of Haematology. 113(2). 422–424. 65 indexed citations
13.
Dearden, Claire, Estella Matutes, Bruno Cazin, et al.. (2001). High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood. 98(6). 1721–1726. 214 indexed citations
14.
15.
Álvarez, Ana García, Susana Rives, Benet Nomdedeu, & M. A. Pereira. (1999). Massive hemolysis in Clostridium perfringens infection.. PubMed. 84(6). 571–3. 21 indexed citations
16.
Ordï, Jaume, et al.. (1993). Secondary (AA) Amyloidosis Associated With Castleman’s Disease:Report of Two Cases and Review of the Literature. American Journal of Clinical Pathology. 100(4). 394–397. 23 indexed citations
17.
Ribera, Josep‐María, et al.. (1989). [Malignant lymphomas (non-Hodgkin's lymphomas and Hodgkin's disease) associated with infection by the human immunodeficiency virus. Study of 9 cases].. PubMed. 92(8). 302–5. 1 indexed citations
18.
Grañena, A, C Rozmán, Enric Carreras, et al.. (1985). [Bone marrow transplantation in acute leukemia: results in a series of 51 consecutive patients prepared with cyclophosphamide and total body irradiation].. PubMed. 85(12). 479–85. 2 indexed citations
19.
Rozmán, C, et al.. (1979). [Chronic lymphoid leukemia. Survival in relation to clinical stages. Statistical analysis of 95 cases (author's transl)].. PubMed. 72(7). 265–71. 1 indexed citations
20.
Morey, M., C Rozmán, Evarist Feliú, et al.. (1977). [Interest of the staging of chronic lymphocytic leukaemia (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 22(5B). 901–11. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norifumi Tsukamoto Breakdown of academic impact, for papers by Shin Fujisawa Breakdown of academic impact, for papers by Anne Lennard Breakdown of academic impact, for papers by Piero Galieni Breakdown of academic impact, for papers by Bernard Lenormand Breakdown of academic impact, for papers by Françoise Rigal‐Huguet Breakdown of academic impact, for papers by Francesco Onida Breakdown of academic impact, for papers by R. Kuse Breakdown of academic impact, for papers by Rajko Kušec Breakdown of academic impact, for papers by Anna Porwit‐MacDonald
Rankless by CCL
2026